Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zymeworks Inc. (NYSE:NYSE:ZYME) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Jack Spinks - Associate Director of Investor Relations Ken Galbraith - Chair...
VANCOUVER, British Columbia & SEATTLE — Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional…
Enhances alignment with US shareholder base and other peer biotechnology companiesPositions company for growth while helping to reduce complexity and certain administrative costsThe Company’s name, brand, and ticker symbol to remain unchangedVANCOUVER, British Columbia & SEATTLE--(BUSINESS WIRE)--Zymeworks Inc. (“Zy...
Dr. Moore will lead Zymeworks’ Early Research & Development Group responsible for advancing the Company’s next-generation of multispecific antibody programs and antibody drug... | June 27, 2022
Lisa M. Coussens, PhD, FAACR, the 2022 to 2023 American Association for Cancer Research president, aims to make mentorship and education — for both junior faculty and undergraduate and high school students — a core focus of her term.Healio spoke with Coussens, who also serves as chair of the cell, development and cancer biology department at Oregon Health & Science